Here, in this randomized, double-blind, placebo-controlled trial, participants ( n = 98) were randomly assigned to 48 weeks of once-weekly subcutaneous retatrutide (1, 4, 8 or 12 mg dose) or placebo
If it's half the market rate, question the quality
The NHS and NICE Clinical Knowledge Summaries recommend established treatments with proven efficacy and safety profiles
This ensures your device runs well without safety or efficiency issues
Step 2: Choose your formats
You cannot choose to lose fat only from your stomach, arms, thighs, or another specific area with a treatment that works throughout the body